Radiochemistry & Molecular Imaging Probes
Overview
At Memorial Sloan Kettering, researchers have translated numerous new radiopharmaceuticals into the clinic for both imaging and therapy purposes. The Radiochemistry and Molecular Imaging Probe (RMIP) Core Facility serves these investigators by supplying a variety of radiopharmaceuticals , including radiolabeled small molecules, peptides, antibodies, and nanoparticles that can be imaged by methods such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT). It also supplies nonradioactive molecular imaging probes for use with non-nuclear detection systems. Our services support both basic research investigations and patient imaging.
Radiopharmacist Serge Lyashchenko preparing a reagent in the cyclotron facility.
Radiochemistry and Molecular Imaging Probe Core
Featured News
People
Director
Members
Scientific Director
RMIP Core Radiopharmacist
RMIP Core Radiopharmacist
Manager, RMIP Core Manufacturing
Lead, Nuclear Pharmacist
Radiopharmacy Tech I
RMIP Core Systems Specialist
RMIP Core Project Manager
Manager, RMIP Core Manufacturing
Sr. Radiopharmacy Technician
Research Technician, Sr.
Alumni
Radiopharmacy QA Specialist
RMIP Core Radiopharmacist
Clinical Radiochemist
Senior Cyclotron Engineer
Project Manager, Funds
Clinical Radiochemist
Clinical Radiochemist
Cyclotron Engineer
Cyclotron Engineer
Senior Research Technician
RMIP Core Radiopharmacist
Lead, Nuclear Pharmacist
RMIP Core Radiopharmacist
